Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
about
Systematic association mapping identifies NELL1 as a novel IBD disease geneIntestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2Crohn's disease and early exposure to domestic refrigerationCentral role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human geneticsGenetic Association of Peptidoglycan Recognition Protein Variants with Inflammatory Bowel DiseaseA proposed classification of the immunological diseasesVariants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitisInteraction of Crohn's disease susceptibility genes in an Australian paediatric cohortMolecular reclassification of Crohn's disease by cluster analysis of genetic variantsUse of antibiotics in the treatment of Crohn's diseaseMycobacteria in Crohn’s disease: how innate immune deficiency may result in chronic inflammationImmunology of Crohn's DiseaseNew serological markers in inflammatory bowel disease are associated with complicated disease behaviourInflammatory bowel diseaseDefects in mucosal immunity leading to Crohn's diseaseCrohn's disease risk alleles on the NOD2 locus have been maintained by natural selection on standing variationRevisiting Crohn's disease as a primary immunodeficiency of macrophagesRecent Insights Into the Genetics of Inflammatory Bowel DiseaseGenome-wide association defines more than 30 distinct susceptibility loci for Crohn's diseaseCrohn's disease: an immune deficiency stateInnate immunity in inflammatory bowel disease: a disease hypothesisProbiotics for maintenance of remission in Crohn's diseaseProbiotics for the maintenance of remission in Crohn's diseaseLinkage analysis in the next-generation sequencing eraMutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndromeBinding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICAActivation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replicationIL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanismGRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cellsBlau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulatorsGalectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasionNOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophagesMembrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognitionMutations in NALP12 cause hereditary periodic fever syndromesEvaluation of Nod-like receptor (NLR) effector domain interactionsCarrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cellsProtein tyrosine phosphatase non-receptor type 22 modulates NOD2-induced cytokine release and autophagyReciprocal cross-talk between Nod2 and TAK1 signaling pathwaysControl of NOD2 and Rip2-dependent innate immune activation by GEF-H1A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling
P2860
Q21090112-982D01F8-4234-4DE4-B0AD-268CA8BA1822Q21090700-30F92604-4C4D-4BC2-BDAD-5CE3704D3046Q21092151-FBDFEB60-DF19-485D-93FC-38C1ABFBD206Q21131205-CB4DCA6B-4088-48CC-9392-B5DB3880915DQ21133003-29E8D592-77AE-464E-B0E0-526F5D058C98Q21144701-B44497F8-BCE5-42ED-A70F-3C62A3BD0D5FQ21145893-60E2017F-F58B-4367-BF4B-D3EF17FDE47FQ21562133-B34E358C-CE8F-4FF4-863F-D6F476F2CAE9Q21562166-6FCCAFBA-C9C8-4EC3-8C69-6B7D870BFE5FQ22241216-33E0C87D-3CA2-4D33-A91C-8954B3EF5CF2Q22241484-91BB09F8-F165-478F-8491-E46E236A042DQ22241677-7BC7DE16-5E11-45DE-8AF0-A0EDC457DA2DQ22242048-3C1CADCB-1FB1-4066-A5C0-A3D705BE2F7CQ22242222-8103C944-3929-409B-81C3-47F81D3F6575Q22242645-77C0CD33-A90E-4F9E-934C-3007F62B4347Q22242851-0642E3EC-6A44-4DF5-B1C7-FC61D06ADB54Q22242983-CCF75234-94EE-4BC2-80A0-7F8209C2DFF3Q22250935-254024EF-80FF-4306-9738-226D0979245FQ22251069-507D82F9-9FF2-414E-85BC-F2FFAEC696CBQ22252579-A387F250-FE45-44BA-B51D-572E2F09A5BFQ22252859-86FA63A2-5FA2-4F03-8A7D-4062D35666DEQ24244110-70754D12-5A7C-4154-910B-636A6CAD63BAQ24246901-FA8F6C25-3355-466D-9543-1AE1447DEEAAQ24289003-0729C37E-65B6-4041-8241-E072E9C9EB92Q24291856-2DC0337F-4BD9-4B8A-87DA-1D41323BDDB1Q24292262-A80336B1-6305-41F1-B9BB-8C9D7A743C1AQ24293059-CC901C10-2BC7-45C7-ADBB-9EC917535174Q24293227-A2B17E8D-3912-4B95-8A9D-9981F56C51DDQ24297555-D2435C4C-BA81-47B4-AC83-704286BAC4F9Q24301721-1452BD1D-1992-4F38-95C9-14899BA6E206Q24301905-075D3AFA-E64F-4A29-A07E-D3F83645A1EAQ24305119-214704DA-8CB3-475E-A1C6-523823185DBAQ24306842-FBAC7E57-D40C-4D54-8795-F7E12C926EE5Q24308730-67511E7D-352F-42CF-AD73-C7F036D9B42AQ24311368-C1864347-966E-44AD-BA72-FD7B45CD76E1Q24313416-B016BBD1-4DF8-49EA-BB6E-FFE47AAF075EQ24321256-A2556BAE-21A6-4FC2-916F-488840ECEC88Q24336336-BA35DCD2-5685-458C-A501-9B05964CDF5AQ24337154-6C64BB35-D7E3-41E0-8878-0FA904FD01E5Q24337563-6F0510F0-B1B8-4F2A-988E-C8838003235B
P2860
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
@ast
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
@en
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
@nl
type
label
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
@ast
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
@en
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
@nl
prefLabel
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
@ast
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
@en
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
@nl
P2093
P50
P3181
P356
P1433
P1476
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
@en
P2093
Belaiche J
Colombel JF
Gower-Rousseau C
Modigliani R
P2888
P304
P3181
P356
10.1038/35079107
P407
P577
2001-05-01T00:00:00Z
P5875
P6179
1031360950